Bilobalide prevents apoptosis through activation of the PI3K/Akt pathway in SH-SY5Y cells
Authors:
- 24 March 2010
- journal article
- research article
- Published by Springer Nature in Apoptosis
- Vol. 15 (6) , 715-727
Abstract
Bilobalide, a sesquiterpene trilactone constituent of Ginkgo biloba leaf extracts, has been proposed to exert protective and trophic effects on neurons. However, mechanisms underlying the protective effects of bilobalide remain unclear. Using human SH-SY5Y neuroblastoma cells and primary hippocampal neurons, this study investigated the neuroprotective effects of bilobalide. We mimicked aging-associated neuronal impairments by applying external factors (beta amyloid protein (Aβ) 1-42, H2O2 and serum deprivation) consequently inducing cell apoptosis. As markers for apoptosis, cell viability, DNA fragmentation, mitochondrial membrane potential and levels of cleaved caspase 3 were measured. We found that, bilobalide prevented Aβ 1-42-, H2O2- and serum deprivation-induced apoptosis. To better understand the neuroprotective effects of bilobalide, we also tested the ability of bilobalide to modulate pro-survival signaling pathways such as protein kinase C (PKC), extracellular-regulated kinase 1/2 (ERK1/2) and phosphatidylinositol 3-kinase (PI3K)/Akt pathways. It was found that, bilobalide dose-dependently increased PI3K activity and levels of phosphorylated Akt (p-Akt Ser473 and Thr308), which could be maintained up to at least 2 h after bilobalide withdrawal in cells treated with or without Aβ 1-42, H2O2 or serum-free medium. In addition, application of PI3K/Akt inhibitor LY294002 could abrogate both the protective effects of bilobalide against Aβ 1-42-, H2O2- and serum deprivation-induced apoptotic cell damage and bilobalide-induced increase in PI3K activity and levels of p-Akt (Ser473 and Thr308). In contrast, application of PKC inhibitor staurosporine (STS) did not affect the protective effects of bilobalide. Moreover, no change in levels of phosphorylated ERK1/2 (p-ERK1/2) was observed in bilobalide-treated cells. These results further suggested that the PI3K/Akt pathway might be involved in the protective effects of bilobalide. Since modern technology allows production of purified bilobalide with high bioavailability, bilobalide may be useful in developing therapy for diseases involving age-associated neurodegeneration.Keywords
This publication has 38 references indexed in Scilit:
- Stimulation of Neurogenesis and Synaptogenesis by Bilobalide and Quercetin via Common Final Pathway in Hippocampal NeuronsJournal of Alzheimer’s Disease, 2009
- Liquid chromatography/atmospheric pressure chemical ionization ion trap mass spectrometry of bilobalide in plasma and brain of rats after oral administration of its phospholipidic complexJournal of Pharmaceutical and Biomedical Analysis, 2009
- Restoration of impaired phosphorylation of cyclic AMP response element‐binding protein (CREB) by EGb 761 and its constituents in Aβ‐expressing neuroblastoma cellsEuropean Journal of Neuroscience, 2007
- Inhibition of PI3-kinase–Akt pathway enhances dexamethasone-induced apoptosis in a human follicular lymphoma cell lineExperimental Cell Research, 2005
- Neuroprotective effects of Ginkgo biloba extractCellular and Molecular Life Sciences, 2003
- Pharmacological Studies Supporting the Therapeutic Use of Ginkgo biloba Extract for Alzheimer’s DiseasePharmacopsychiatry, 2003
- BILOBALIDE AND NEUROPROTECTIONPharmacological Research, 2002
- Serine/Threonine Protein Kinases and ApoptosisExperimental Cell Research, 2000
- Cellular survival: a play in three AktsGenes & Development, 1999
- Regeneration of Motor Nerves in Bilobalide-Treated RatsPlanta Medica, 1993